Tarsus Pharmaceuticals, Inc. TARS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s software and technology licenses, net?
- Tarsus Pharmaceuticals, Inc. (TARS) reported software and technology licenses, net of $715K in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s software and technology licenses, net changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s software and technology licenses, net increased by 16.1% year-over-year, from $616K to $715K.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s software and technology licenses, net has grown at a 87.2% compound annual growth rate (CAGR), from $81K to $1.86M.